Factorial Energy (FAC) up 13.9% in Tuesday's trading as Oppenheimer initiated coverage with an Outperform rating and $8 price target, seeing the company as a leading play in the commercialization of ...

How Recursion is leading a new era of AI-driven drug discovery AI drug discovery is not a new phenomenon – but it is evolving at an almost dizzying pace. Recursion is one of the earliest innovators in ...

Recursion's co-founder and long-serving chief executive, Chris Gibson, has switched to the role of company chair, and will be succeeded in the CEO role by R&D and commercial head Najat Khan. The ...

This price reflects trading activity during the overnight session on the Blue Ocean ATS, available 8 PM to 4 AM ET, Sunday through Thursday, when regular markets are closed. The above button links to ...

Factorial Energy Inc. OverviewElectrical Equipment & Parts / Industrials Factorial Energy Inc. develops and manufactures battery energy storage technologies and solid-state battery technology in the ...

Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company that combines automation, artificial intelligence, machine learning, and in vivo validation capabilities to discover novel ...